Xue Zhang

发表

Network pharmacology suggests biochemical rationale for treating COVID-19 symptoms with a Traditional Chinese Medicine

Kai-zheng Zhang, Yu-fang Wang, Deng-hai Zhang, 2020, Communications Biology.

Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance

Hao Chen, G. Uzan, Limin Xu, 2018, Anti-cancer drugs.

Therapeutic Effects and Related Molecular Mechanisms of Celastrol, a Triterpenoid Natural Compound and Novel HSP90 Inhibitor Extracted from Plants of the Celastraceae Family

G. Uzan, Limin Xu, Fan-fan Cao, 2019, Heat Shock Proteins.

Evaluation of Active Hexose Correlated Compound (Ahcc) on Phase IiDrug Metabolism Pathways and the Implications for Supplement-DrugInteractions

N. Owiti, Judith A. Smith, J. Faro, 2015 .

IP‐FCM platform detects the existence and regulator‐caused dissociation of components in naturally assembled HSP90 complex

G. Uzan, Li-min Xu, Deng-hai Zhang, 2014, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Celastrol targets IRAKs to block Toll-like receptor 4-mediated nuclear factor-κB activation.

G. Uzan, Deng-hai Zhang, Fan-fan Cao, 2016, Journal of integrative medicine.

Celastrol reverses palmitic acid (PA)‐caused TLR4‐MD2 activation‐dependent insulin resistance via disrupting MD2‐related cellular binding to PA

G. Uzan, Deng-hai Zhang, Chun-xin Yang, 2018, Journal of cellular physiology.

In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus

Bin Peng, Deng-hai Zhang, Kun-lun Wu, 2020, Journal of Integrative Medicine.

Celastrol Reverses Palmitic Acid-Induced Insulin Resistance in HepG2 Cells via Restoring the miR-223 and GLUT4 Pathway.

G. Uzan, X. Xue, Deng-hai Zhang, 2019, Canadian journal of diabetes.

Mutations Y493G and K546D in human HSP90 disrupt binding of celastrol and reduce interaction with Cdc37

J. Hou, Deng-hai Zhang, Fan-fan Cao, 2016, FEBS open bio.

Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems

G. Uzan, Li-min Xu, Deng-hai Zhang, 2015, Journal of Neuroimmune Pharmacology.

Network pharmacology suggests biochemical rationale for treating COVID-19 symptoms with a Traditional Chinese Medicine

Kai-zheng Zhang, Yu-fang Wang, Deng-hai Zhang, 2020, Communications Biology.

Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol

G. Uzan, Chun-xin Yang, Bin Peng, 2015, BMC Cancer.

Peptide deformylase inhibitor actinonin reduces celastrol’s HSP70 induction while synergizing proliferation inhibition in tumor cells

G. Uzan, Maoquan Li, Limin Xu, 2014, BMC Cancer.

Effects of celastrol on Tau hyperphosphorylation and expression of HSF‐1 and HSP70 in SH‐SY5Y neuroblastoma cells induced by amyloid‐β peptides

Limin Xu, Bin Peng, Ying Wang, 2018, Biotechnology and applied biochemistry.

Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems

G. Uzan, Li-min Xu, Deng-hai Zhang, 2015, Journal of Neuroimmune Pharmacology.

Ferroptosis inhibitors reduce celastrol toxicity and preserve its insulin sensitizing effects in insulin resistant HepG2 cells.

Deng-hai Zhang, Bin Peng, Xue Zhang, 2024, Journal of integrative medicine.